Showing results (51-60 of 83) with videos related to
Sort By:
Pageof 9
Arthritis and Rheumatism|July 13, 2004
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritisFloris A van Gaalen, Jill van Aken, Tom W J Huizinga, et al.Annals of the Rheumatic Diseases|March 13, 2010
The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritisKlaus P Machold, Robert Landewé, Josef S Smolen, et al.Arthritis and Rheumatism|July 27, 2006
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisJasper J Haringman, Danielle M Gerlag, Tom J M Smeets, et al.Arthritis and Rheumatism|April 13, 2004
Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trialZuzana de Jong, Marten Munneke, Willem F Lems, et al.Arthritis and Rheumatism|September 18, 2003
Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trialZuzana de Jong, Marten Munneke, Aeilko H Zwinderman, et al.Annals of the Rheumatic Diseases|April 25, 2009
Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008Monika Schoels, Daniel Aletaha, Josef S Smolen, et al.Arthritis and Rheumatism|May 1, 2007
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trialHenrike van Dongen, Jill van Aken, Leroy R Lard, et al.Annals of the Rheumatic Diseases|November 13, 2012
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementMonika M Schoels, Désirée van der Heijde, Ferdinand C Breedveld, et al.Arthritis and Rheumatism|August 9, 2003
Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissuesTineke C T M van der Pouw Kraan, Floris A van Gaalen, Pia V Kasperkovitz, et al.Arthritis and Rheumatism|March 31, 2006
Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymesJudith A M Wessels, Jeska K de Vries-Bouwstra, Bas T Heijmans, et al.Pageof 9